clinical trial · NCT05119920
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
Dry Eye DiseaseKerato Conjunctivitis SiccaPilocarpine Ophthalmic Topical Cream, Dose 1Pilocarpine Ophthalmic Topical Cream, Dose 2Pilocarpine Ophthalmic Topical Cream, Dose 3Placebo Ophthalmic Topical Cream
brief summary
This is a Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Signs and Symptoms of Dry Eye Disease.
started
Jan 3, 2022
primary completion
Jul 27, 2022
completion
Jul 27, 2022
last updated
Jul 12, 2023
official title
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream BID for the Treatment of Signs and Symptoms of Dry Eye Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol